CANON MEDICAL RESEARCH EUROPE, LIMITED
Get an alert when CANON MEDICAL RESEARCH EUROPE, LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-11 (in 1y)
Last made up 2026-04-27
Watchouts
None on the register
Cash
£9M
+17.9% vs 2023
Net assets
£11M
+15% vs 2023
Employees
133
-1.5% vs 2023
Profit before tax
£5M
+13.8% vs 2023
Name history
Renamed 3 times since incorporation
- CANON MEDICAL RESEARCH EUROPE, LIMITED 2018-01-04 → present
- TOSHIBA MEDICAL VISUALIZATION SYSTEMS EUROPE, LIMITED 2008-11-12 → 2018-01-04
- TOSHIBA MEDICAL VISUALIZATION SYSTEMS LIMITED 2008-09-03 → 2008-11-12
- DUNWILCO (1555) LIMITED 2008-04-22 → 2008-09-03
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £16,878,000 | £17,781,000 | |
| Operating profit | £4,000,000 | £4,515,000 | |
| Profit before tax | £4,031,000 | £4,587,000 | |
| Net profit | £3,030,000 | £3,375,000 | |
| Cash | £7,854,000 | £9,258,000 | |
| Total assets less current liabilities | £9,355,000 | £10,760,000 | |
| Net assets | £9,355,000 | £10,760,000 | |
| Equity | £9,355,000 | £10,760,000 | |
| Average employees | 135 | 133 | |
| Wages | £8,514,000 | £8,841,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 23.7% | 25.4% | |
| Net margin | 18.0% | 19.0% | |
| Return on capital employed | 42.8% | 42.0% | |
| Current ratio | 6.15x | 6.63x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company's net asset position has moved from £9,355,000 (2023) to £10,760,000 (2024). The profitability remained strong and positive, increasing from £3,030,000 (2023) to £3,375,000 (2024). Even though the Company expects some budget reduction in 2025, after reviewing the Company's forecast and projections, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for a period of at least 12 months. The Company therefore continues to adopt the going concern basis in preparing its financial statements.”
Significant events
- “The restructuring plan has been agreed during 2025 as part of change in the focus of the group from Healthcare IT business to Canon Medical Modality business which will be implemented in 2025 with an estimated financial impact of £560,000.”
- “The Company has been awarded £3.6million from Scottish Enterprise towards a £14million project that uses AI for faster data analysis and aims to improve medical scans with benefits for both patients and health services. The Company will use the grant to undertake R&D to develop SMART modalities and safeguard 100 jobs.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
8 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SUTHARSHAN, Jamuna | Secretary | 2026-01-01 | — | — |
| ANDERSON, Jannine Mary | Director | 2026-01-01 | Jun 1979 | British |
| DONOHOE, Mark | Director | 2025-08-01 | Oct 1972 | British |
| KOGA, Akihiro | Director | 2022-03-28 | Sep 1967 | Japanese |
| MATSUMOTO, Kazuto | Director | 2026-04-01 | Mar 1970 | Japanese |
| SMOUT, Andrew, Dr | Director | 2019-10-01 | Apr 1963 | British |
| SUTHERLAND, Ken Gavin Neil, Dr | Director | 2013-04-15 | Jun 1967 | British |
| TAKADA, Yoichi | Director | 2022-03-28 | Oct 1966 | Japanese |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DONOHOE, Mark | Secretary | 2022-01-14 | 2026-01-01 |
| FRIEDBERG, Fredric | Secretary | 2008-10-10 | 2017-04-01 |
| HYDE, Peter | Secretary | 2017-04-20 | 2022-01-14 |
| D.W. COMPANY SERVICES LIMITED | Corporate Secretary | 2008-04-22 | 2008-10-10 |
| AOYAMA, Hiroshi | Director | 2008-11-19 | 2010-06-24 |
| ASAHINA, Hiroshi | Director | 2008-11-19 | 2010-12-16 |
| FRIEDBERG, Fredric | Director | 2008-10-10 | 2017-04-01 |
| IKEDA, Satoshi | Director | 2020-01-01 | 2021-06-01 |
| KAMIJIMA, Chikao | Director | 2008-11-19 | 2014-07-01 |
| KOMATSU, Kenichi, Dr | Director | 2008-11-19 | 2010-06-24 |
| KURA, Hiroyuki | Director | 2011-04-23 | 2016-07-01 |
| LAWRIE, Colin Thomas | Director | 2008-09-30 | 2008-10-10 |
| NAKAZATO, Toshiaki | Director | 2008-11-19 | 2009-05-14 |
| NOBUTA, Yasuo | Director | 2016-07-01 | 2019-10-01 |
| SAKAMITSU, Yoshiyuki | Director | 2014-07-01 | 2022-09-12 |
| SASAKI, Naoki | Director | 2016-07-01 | 2022-03-28 |
| SHIMONO, Yoshinori | Director | 2022-09-12 | 2026-04-01 |
| SUGIHARA, Naoki | Director | 2020-04-01 | 2022-03-28 |
| TACHIKAWA, Hiroyuki | Director | 2014-07-01 | 2016-07-01 |
| TACHIZAKI, Hisashi | Director | 2016-07-01 | 2018-07-20 |
| TAKADA, Yoichi | Director | 2018-07-20 | 2020-04-01 |
| TANAKA, Keiji | Director | 2010-06-24 | 2014-07-01 |
| TSUNAKAWA, Satoshi | Director | 2010-06-24 | 2013-04-10 |
| D.W. COMPANY SERVICES LIMITED | Corporate Director | 2008-09-30 | 2008-11-19 |
| D.W. DIRECTOR 1 LIMITED | Corporate Director | 2008-04-22 | 2008-11-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Ken Gavin Neil Sutherland | Individual | Significant influence | 2016-05-01 | Active |
Filing timeline
Last 20 of 114 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-04-14 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-14 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-20 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2026-01-13 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-11-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-08 | AA | accounts | Accounts with accounts type full | |
| 2025-01-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-26 | AAMD | accounts | Accounts amended with accounts type full | |
| 2024-07-18 | AA | accounts | Accounts with accounts type full | |
| 2024-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-19 | AA | accounts | Accounts with accounts type full | |
| 2023-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-13 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-13 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-11 | AA | accounts | Accounts with accounts type full | |
| 2022-03-29 | AP01 | officers | Appoint person director company with name date | |
| 2022-03-29 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 0
- Officers appointed
- 4
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+5.4%
£16,878,000 £17,781,000
-
Cash
+17.9%
£7,854,000 £9,258,000
-
Net assets
+15%
£9,355,000 £10,760,000
-
Employees
-1.5%
135 133
-
Operating profit
+12.9%
£4,000,000 £4,515,000
-
Profit before tax
+13.8%
£4,031,000 £4,587,000
-
Wages
+3.8%
£8,514,000 £8,841,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers